Syncom Formulations (India) Limited (SYNCOMF) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.007x

Based on the latest financial reports, Syncom Formulations (India) Limited (SYNCOMF) has a cash flow conversion efficiency ratio of 0.007x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs17.58 Million ≈ $190.08K USD) by net assets (Rs2.70 Billion ≈ $29.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Syncom Formulations (India) Limited (SYNCOMF) total market value for the company's overall valuation and market capitalisation.

Syncom Formulations (India) Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Syncom Formulations (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Syncom Formulations (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Syncom Formulations (India) Limited ranked by their cash flow conversion efficiency. Explore how high is Syncom Formulations (India) Limited's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Capstone Energy Plus, Inc. Common Stock
NASDAQ:CEPL
0.182x
Inscobee
KO:006490
0.020x
ST.GEORGE MINING LTD
F:S0G
N/A
Avita Medical Inc
AU:AVH
0.411x
In The F
KO:014990
0.009x
Gulf Island Fabrication Inc
NASDAQ:GIFI
0.030x
Iron Force Industrial Co Ltd
TW:2228
0.080x
SOL-GEL TECHN. IS-10
F:4SG
N/A

Annual Cash Flow Conversion Efficiency for Syncom Formulations (India) Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Syncom Formulations (India) Limited from 2006 to 2025. View Syncom Formulations (India) Limited share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs3.42 Billion
≈ $37.00 Million
Rs234.36 Million
≈ $2.53 Million
0.068x +430.29%
2024-03-31 Rs2.87 Billion
≈ $31.07 Million
Rs-59.58 Million
≈ $-644.37K
-0.021x -150.42%
2023-03-31 Rs2.56 Billion
≈ $27.69 Million
Rs105.29 Million
≈ $1.14 Million
0.041x -44.03%
2022-03-31 Rs2.22 Billion
≈ $24.03 Million
Rs163.29 Million
≈ $1.77 Million
0.073x +791.44%
2021-03-31 Rs1.88 Billion
≈ $20.29 Million
Rs-19.93 Million
≈ $-215.59K
-0.011x -206.10%
2020-03-31 Rs1.46 Billion
≈ $15.75 Million
Rs-5.06 Million
≈ $-54.69K
-0.003x -110.64%
2019-03-31 Rs1.33 Billion
≈ $14.34 Million
Rs43.29 Million
≈ $468.17K
0.033x +348.68%
2018-03-31 Rs1.22 Billion
≈ $13.19 Million
Rs-16.01 Million
≈ $-173.10K
-0.013x -111.13%
2017-03-31 Rs1.17 Billion
≈ $12.69 Million
Rs138.41 Million
≈ $1.50 Million
0.118x -46.97%
2016-03-31 Rs1.09 Billion
≈ $11.76 Million
Rs241.74 Million
≈ $2.61 Million
0.222x +11832.06%
2015-03-31 Rs1.00 Billion
≈ $10.84 Million
Rs1.87 Million
≈ $20.20K
0.002x -97.36%
2014-03-31 Rs951.99 Million
≈ $10.30 Million
Rs67.30 Million
≈ $727.87K
0.071x +7.30%
2013-03-31 Rs877.09 Million
≈ $9.49 Million
Rs57.79 Million
≈ $624.96K
0.066x -14.20%
2012-03-31 Rs836.08 Million
≈ $9.04 Million
Rs64.20 Million
≈ $694.33K
0.077x +281.55%
2011-03-31 Rs816.58 Million
≈ $8.83 Million
Rs-34.54 Million
≈ $-373.52K
-0.042x -381.24%
2010-03-31 Rs550.47 Million
≈ $5.95 Million
Rs-4.84 Million
≈ $-52.32K
-0.009x +51.59%
2009-03-31 Rs411.32 Million
≈ $4.45 Million
Rs-7.47 Million
≈ $-80.76K
-0.018x -112.90%
2008-03-31 Rs390.34 Million
≈ $4.22 Million
Rs54.94 Million
≈ $594.11K
0.141x -0.43%
2007-03-31 Rs342.37 Million
≈ $3.70 Million
Rs48.40 Million
≈ $523.37K
0.141x +69.71%
2006-03-31 Rs292.59 Million
≈ $3.16 Million
Rs24.37 Million
≈ $263.55K
0.083x --

About Syncom Formulations (India) Limited

NSE:SYNCOMF India Drug Manufacturers - Specialty & Generic
Market Cap
$188.37 Million
Rs17.42 Billion INR
Market Cap Rank
#16848 Global
#866 in India
Share Price
Rs18.53
Change (1 day)
-4.78%
52-Week Range
Rs10.30 - Rs21.39
All Time High
Rs26.77
About

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and su… Read more